The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling
Open accessAbstract
Genome‐scale metabolic models ( GEM s) have proven useful as scaffolds for the integration of omics data for understanding the genotype–phenotype relationship in a mechanistic manner. Here, we evaluated the presence/absence of proteins encoded by 15,841 genes in 27 hepatocellular carcinoma (HCC) patients using immunohistochemistry. We used this information to reconstruct personalized GEM s for six HCC patients based on the proteomics data, HMR 2.0, and a task‐driven model reconstruction algorithm ( tINIT ). The personalized GEM s were employed to identify anticancer drugs using the concept of antimetabolites; i.e., drugs that are structural analogs to metabolites. The toxicity of each antimetabolite was predicted by assessing the in silico functionality of 83 healthy cell type‐specific GEM s, which were also reconstructed with the tINIT algorithm. We predicted 101 antimetabolites that could be effective in preventing tumor growth in all HCC patients, and 46 antimetabolites which were specific to individual patients. Twenty‐two of the 101 predicted antimetabolites have already been used in different cancer treatment strategies, while the remaining antimetabolites represent new potential drugs. Finally, one of the identified targets was validated experimentally, and it was confirmed to attenuate growth of the HepG2 cell line.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Towards a knowledge-based Human Protein Atlas
Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1210-1248 · Cited by 2,440
Self-citationA Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics
Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A.-K., Amini, B., Andersen, E., Andersson, A.-C., Angelidou, P., Asplund, A., Asplund, C., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500279-mcp200 · Cited by 1,540
Self-citationTargeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
Personal omics profiling reveals dynamic molecular and medical phenotypes
Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.009 · Cited by 1,291
A community-driven global reconstruction of human metabolism
Thiele, I., Swainston, N., Fleming, R. M. T., Hoppe, A., Sahoo, S., Aurich, M. K., Haraldsdottir, H., Mo, M. L., Rolfsson, O., Stobbe, M. D., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2488 · Cited by 1,019
Self-citationPredictive, personalized, preventive, participatory (P4) cancer medicine
Hood, L., & Friend, S. H. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.227 · Cited by 900
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., & Nielsen, J. (2014) · Nature Communications · doi:10.1038/ncomms4083 · Cited by 519
Self-citationThe Etiology of Hepatocellular Carcinoma and Consequences for Treatment
Sanyal, A. J., Yoon, S. K., & Lencioni, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-14 · Cited by 517
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N., MacKenzie, E. D., Jerby, L., Micaroni, M., Chaneton, B., Adam, J., Hedley, A., et al. (2011) · Nature · doi:10.1038/nature10363 · Cited by 503
Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., Huang, P., Sawyer, S. K., Fuerth, B., Faubert, B., et al. (2011) · Genes & Development · doi:10.1101/gad.1987211 · Cited by 490
Predicting selective drug targets in cancer through metabolic networks
Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., & Shlomi, T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.35 · Cited by 476
Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., & Wu, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 469
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N., Nookaew, I., & Nielsen, J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002518 · Cited by 430
Self-citationAgren, R., Liu, L., Shoaie, S., Vongsangnak, W., Nookaew, I., & Nielsen, J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002980 · Cited by 415
Self-citationCancer metabolism: current perspectives and future directions
Muñoz-Pinedo, C., El Mjiyad, N., & Ricci, J.-E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.123 · Cited by 385
L-Carnitine - Metabolic Functions and Meaning in Humans Life
Pekala, J., Patkowska-Sokola, B., Bodkowski, R., Jamroz, D., Nowakowski, P., Lochynski, S., & Librowski, T. (2011) · Current Drug Metabolism · doi:10.2174/138920011796504536 · Cited by 339
Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
Ishizuka, M., Abe, F., Sano, Y., Takahashi, K., Inoue, K., Nakajima, M., Kohda, T., Komatsu, N., Ogura, S.-I., & Tanaka, T. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.029 · Cited by 255
Integration of clinical data with a genome‐scale metabolic model of the human adipocyte
Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., Walley, A. J., Froguel, P., Carlsson, L. M., Uhlen, M., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.5 · Cited by 239
Self-citationRevolutionizing medicine in the 21st century through systems approaches
Hood, L., Balling, R., & Auffray, C. (2012) · Biotechnology Journal · doi:10.1002/biot.201100306 · Cited by 236
Kampf, C., Olsson, I., Ryberg, U., Sjöstedt, E., & Pontén, F. (2012) · Journal of Visualized Experiments · doi:10.3791/3620 · Cited by 196
Self-citationInflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion
Khasawneh, J., Schulz, M. D., Walch, A., Rozman, J., de Angelis, M. H., Klingenspor, M., Buck, A., Schwaiger, M., Saur, D., Schmid, R. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802864106 · Cited by 182
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
Borena, W., Strohmaier, S., Lukanova, A., Bjørge, T., Lindkvist, B., Hallmans, G., Edlinger, M., Stocks, T., Nagel, G., Manjer, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26338 · Cited by 177
Integrative genome‐scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery
Kim, H. U., Kim, S. Y., Jeong, H., Kim, T. Y., Kim, J. J., Choy, H. E., Yi, K. Y., Rhee, J. H., & Lee, S. Y. (2011) · Molecular Systems Biology · doi:10.1038/msb.2010.115 · Cited by 160
Systems medicine and metabolic modelling
Mardinoğlu, A., & Nielsen, J. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02493.x · Cited by 140
Self-citationRecent advances in the treatment of hepatocellular carcinoma
Singal, A. G., & Marrero, J. A. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283383ca5 · Cited by 131
Recent advances in the treatment of hepatocellular carcinoma
Padhya, K. T., Marrero, J. A., & Singal, A. G. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835ff1cf · Cited by 118
Genome‐scale modeling of human metabolism – a systems biology approach
Mardinoğlu, A., Gatto, F., & Nielsen, J. (2013) · Biotechnology Journal · doi:10.1002/biot.201200275 · Cited by 117
Self-citationPacilli, A., Calienni, M., Margarucci, S., D’Apolito, M., Petillo, O., Rocchi, L., Pasquinelli, G., Nicolai, R., Koverech, A., Calvani, M., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt030 · Cited by 114
Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?
Finn, R. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2084 · Cited by 99
Ye, G., Zhu, B., Yao, Z., Yin, P., Lu, X., Kong, H., Fan, F., Jiao, B., & Xu, G. (2012) · Journal of Proteome Research · doi:10.1021/pr300502v · Cited by 75
Antibody-based tissue profiling as a tool for clinical proteomics
Kampf, C., Andersson, A., Wester, K., Björling, E., Uhlén, M., & Pontén, F. (2004) · Clinical Proteomics · doi:10.1385/cp:1:3-4:285 · Cited by 71
Self-citationPotential for statins in the chemoprevention and management of hepatocellular carcinoma
Lonardo, A., & Loria, P. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07232.x · Cited by 67
Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation
Toshima, T., Shirabe, K., Matsumoto, Y., Yoshiya, S., Ikegami, T., Yoshizumi, T., Soejima, Y., Ikeda, T., & Maehara, Y. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0835-9 · Cited by 63
l ‐carnitine and cancer cachexia: Clinical and experimental aspects
Silvério, R., Laviano, A., Fanelli, F. R., & Seelaender, M. C. L. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0017-7 · Cited by 63
Quantitative estimation of absorption and degradation of a carnitine supplement by human adults
Rebouche, C. J. (1991) · Metabolism · doi:10.1016/0026-0495(91)90033-s · Cited by 59
Novel insights into obesity and diabetes through genome-scale metabolic modeling
Väremo, L., Nookaew, I., & Nielsen, J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00092 · Cited by 52
Self-citationGarg, D., Henrich, S., Salo‐Ahen, O. M. H., Myllykallio, H., Costi, M. P., & Wade, R. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901869w · Cited by 49
Roles of Tetrahydrobiopterin in Promoting Tumor Angiogenesis
Chen, L., Zeng, X., Wang, J., Briggs, S. S., O’Neill, E., Li, J., Leek, R., Kerr, D. J., Harris, A. L., & Cai, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100025 · Cited by 40
Lazar, M. A., & Birnbaum, M. J. (2012) · Science · doi:10.1126/science.1221834 · Cited by 38
Cuthbert, J. A., & Lipsky, P. E. (1997) · PubMed · Cited by 28
The impact of molecular targets in cancer drug development: major hurdles and future strategies
Hebar, A., Valent, P., & Selzer, E. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.71 · Cited by 27
Cited by
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Self-citationA pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.001 · Cited by 851
Current status and applications of genome-scale metabolic models
Gu, C., Kim, G. B., Kim, W. J., Kim, H. U., & Lee, S. Y. (2019) · Genome Biology · doi:10.1186/s13059-019-1730-3 · Cited by 785
Robinson, J. L., Kocabaş, P., Wang, H., Cholley, P.-E., Cook, D., Nilsson, A., Anton, M., Ferreira, R., Domenzain, I., Billa, V., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1482 · Cited by 442
Self-citation
Metadata
- Authors
- Agren, R., Mardinoglu, A., Asplund, A., Kampf, C., Uhlen, M., & Nielsen, J.
- Venue
- Molecular Systems Biology
- Published
- 2014-03
- Volume
- 10
- Issue
- 3
- Pages
- 721-721
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W2124653577
- Cited by
- 387
- References
- 48
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.